EFFECTS OF VALSARTAN ON STRESS-INDUCED CHANGES OF SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AND NITRIC OXIDE IN MICE

REFERENCES

• Barsotti A., Di Napoli P., Taccardi A. A., Spina R., Stuppia L., Palka G., Barbacene R. C., De Caterina R., Conti P. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: Evidence of an e-NOS mRNA overexpression after global ischemia. Atherosclerosis 2001; 155: 53–59, [INFOTRIEVE], [CSA]
   Google Scholar
• Boer C., Scheffer G. J., de Lange J. J., Westerhof N., Sipkema P. Alpha-1-adrenoceptor stimulation induces nitric oxide release in rat pulmonary arteries. Journal of Vascular Research 1999; 36: 79–81, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Celletti F. L., Hilfiker P. R., Ghafouri P., Dake M. D. Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque. Journal of the American College of Cardiology 2001; 37: 2126–2130, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chua C. C., Hamdy R. C., Chua B. H. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochimica et Biophysica Acta 1998; 1401: 187–194, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Colasanti M., Suzuki H. The dual personality of NO. Trends in Pharmacological Sciences 2000; 21: 249–252, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cordellini S., Vassilieff V. S. Decreased endothelium-dependent vasoconstriction to noradrenaline in acute-stressed rats is potentiated by previous chronic stress: Nitric oxide involvement. General Pharmacology 1998; 30: 79–83, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Dadmarz M., Burg Cx˙ vx˙ d., Milakofsky L., Hofford J. M., Vogel W. H. Effects of stress on amino acids and related compounds in various tissues of fasted rats. Life Sciences 1998; 63: 1485–1491, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Esch T., Stefano G. B., Fricchione G. L., Benson H. Stress-related diseases—a potential role for nitric oxide. Medical Science Monitor 2002; 8: 103–118, [CSA]
   Google Scholar
• Ferrer M., Balfagon G. Aging alters neuronal nitric oxide release from rat mesenteric arteries: Role of presynaptic beta-adrenoceptors. Clinical Science (London, England) 2001; 101: 321–328, [CSA]
   Google Scholar
• Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney International 1999; 56: 794–814, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995; 1: 27–31, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fredriksson J. M., Lindquist J. M., Bronnikov G. E., Nedergaard J. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. The Journal of Biological Chemistry 2000; 275: 13802–13811, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Grossmann J., Burkhardt R., Harder S., Lenz T., Sedlmeyer A., Klinkhardt U., Haak T., Geiger H., Scheuermann E. H. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: A placebo-controlled study in healthy volunteers. Clinical Pharmacology and Therapeutics 2000; 68: 501–509, [CSA], [CROSSREF]
   Google Scholar
• Guan S., Wang B. Effects of fosinopril and valsartan on expressions of ICAM-1 and NO in human umblical vein endothelial cells. Chinese Medical Journal (Eng) 2003; 116: 923–927, [CSA]
   Google Scholar
• Inoue M., Itoh H., Ueda M., Naruko T., Kojima A., Komatsu R., Doi K., Ogawa Y., Tamura N., Takaya K., Igaki T., Yamashita J., Chun T. H., Masatsugu K., Becker A. E., Nakao K. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108–2116, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jezova D., Ochedalski T., Kiss A., Aguilera G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. Journal of Neuroendocrinology 1998; 10: 67–72, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kalinowski L., Matys T., Chabielska E., Buczko W., Malinski T. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Hypertension 2002; 40: 521–527, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kim H. W., Greenburg A. G. Contraction coupled endothelial nitric oxide release: A new paradigm for local vascular control?. The Journal of Surgical Research 2001; 100: 93–98, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Klingbeil A. U., John S., Schneider M. P., Jacobi J., Handrock R., Schmieder R. E. Effect of AT1 receptor blockade on endothelial function in essential hypertension. American Journal of Hypertension 2003; 16: 123–128, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Komatsu R., Ueda M. Plaque progression and destabilization in human coronary arteries. Nippon Rinsho 1998; 56: 2477–2482, [INFOTRIEVE], [CSA]
   Google Scholar
• Leza J. C., Salas E., Sawicki G., Russell J. C., Radomski M. W. The effects of stress on homeostasis in JCR-LA-cp rats: The role of nitric oxide. The Journal of Pharmacology and Experimental Therapeutics 1998; 286: 1397–1403, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Maloney J. P., Silliman C. C., Ambruso D. R., Wang J., Tuder R. M., Voelkel N. F. In vitro release of vascular endothelial growth factor during platelet aggregation. The American Journal of Physiology 1998; 275: 1054–1061, [CSA]
   PubMed Web of Science ®Google Scholar
• Malyshev I. Y., Manukhina E. B. Stress, adaptation, and nitric oxide. Biochemistry Biokhimiia 1998; 63: 840–853, [CSA]
   PubMed Web of Science ®Google Scholar
• Matsubara H., Fujiyama S., Iba O., Amano K., Iwasaka T. Angiogenesis and angiotensin II: Differential postnatal angiogenic activities unmasked by gene-engineered mouse models of angiotensin AT1 and AT2 receptor subtypes. Nippon Rinsho 2002; 60: 1911–1915, [INFOTRIEVE], [CSA]
   Google Scholar
• Mervaala E. M., Muller D. N., Park J. K., Schmidt F., Lohn M., Breu V., Dragun D., Ganten D., Haller H., Luft F. C. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 1999; 33: 389–395, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Milakofsky L., Hare T. A., Miller J. M., Vogel W. H. Rat plasma levels of amino acids and related compounds during stress. Life Sciences 1985; 36: 753–761, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Milakofsky L., Harris N., Vogel W. H. Effect of repeated stress on a number of plasma amino acids and related compounds in young and old rats. Physiology & Behavior 1996; 60: 969–971, [CSA]
   Google Scholar
• Navarro-Oliveira C. M., Vassilieff V. S., Cordellini S. The sympathetic adrenomedullary system, but not the hypothalamic-pituitary-adrenal axis, participates in aorta adaptive response to stress: Nitric oxide involvement. Autonomic Neuroscience 2000; 83: 140–147, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Olivenza R., Moro M. A., Lizasoain I., Lorenzo P., Fernandez A. P., Rodrigo J., Bosca L., Leza J. C. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. Journal of Neurochemistry 2000; 74: 785–791, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Persoons J. H., Moes N. M., Broug-Holub E., Schornagel K., Tilders F. J., Kraal G. Acute and long-term effects of stressors on pulmonary immune functions. American Journal of Respiratory Cell and Molecular Biology 1997; 17: 203–208, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Peters S. Can angiotensin receptor antagonists prevent restenosis after stent placement? American Journal of Cardiovascular Drugs 2002; 2: 143–148, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Pueyo M. E., Arnal J. F., Rami J., Michel J. B. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. The American Journal of Physiology 1998a; 274: 214–220, [CSA]
   PubMed Web of Science ®Google Scholar
• Pueyo M. E., Chen Y., D'Angelo G., Michel J. B. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. Experimental Cell Research 1998b; 238: 354–358, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Siragy H. M., Awad A., Abadir P., Webb R. The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats. Endocrinology 2003; 144: 2229–2233, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Sydow K., Munzel T. ADMA and oxidative stress. Atherosclerosis Supplements 2003; 4: 41–51, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Szabo B., Hedler L., Schurr C., Starke K. Peripheral presynaptic facilitatory effect of angiotensin II on noradrenaline release in anesthetized rabbits. Journal of Cardiovascular Pharmacology 1990; 15: 968–975, [INFOTRIEVE], [CSA]
   Google Scholar
• Tamarat R., Silvestre J. S., Kubis N., Benessiano J. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension 2002; 39: 830–835, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Tonello C., Giordano A., Cozzi V., Cinti S., Stock M. J., Carruba M. O., Nisoli E. Role of sympathetic activity in controlling the expression of vascular endothelial growth factor in brown fat cells of lean and genetically obese rats. FEBS Letters 1999; 442: 167–172, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tsurumi Y., Murohara T., Krasinski K., Chen D., Witzenbichler B., Kearney M., Couffinhal T., Isner J. M. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Medicine 1997; 3: 879–886, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B. S., Karoui H., Tordo P., Pritchard K. A., Jr. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proceedings of the National Academy of Sciences of the United States of America 1998; 95: 9220–9225, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Williams B., Baker A. Q., Gallacher B., Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 1995; 25: 913–917, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wright J. W., Hardling J. W. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Research Reviews 1992; 17: 227–262, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wright J. W., Hardling J. W. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neuroscience and Biobehavioral Reviews 1994; 18: 21–53, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wu L., Iwai M., Nakagami H., Li Z., Chen R., Suzuki J., Akishita M., de Gasparo M., Horiuchi M. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 2001; 104: 2716–2721, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yang G., Xi Z., Wan Y., Wang H., Bi G. Changes in circulating and tissue angiotensin II during acute and chronic stress. Biological Signals 1993; 2: 166–172, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Yang G., Wan Y., Zhu Y. Angiotensin II—an important stress hormone. Biological Signals 1996; 5: 1–8, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Yu C. M., Tipoe G. L., Wing-Hon Lai K., Lau Cx˙ P. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. Journal of the American College of Cardiology 2001; 38: 1207–1215, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Zachary I., Mathur A., Yla-Herttuala S., Martin J. Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arteriosclerosis, Thrombosis, and Vascular Biology 2000; 20: 1512–1520, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Zimmerman B. G., Sybertz E. J., Wong P. C. Interaction between sympathetic and renin-angiotensin system. Journal of Hypertension 1984; 2: 581–587, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar